A Comprehensive Approach to Secondary HIV Prevention and Care Among Positives
NCT ID: NCT01935440
Last Updated: 2018-07-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
632 participants
INTERVENTIONAL
2012-11-01
2017-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Network & Dyad HIV Prevention Intervention for IDU's - 1
NCT00218335
A Peer-Oriented HIV Prevention Outreach Program for Individuals at High Risk for HIV and Other STIs
NCT00183456
Secondary HIV Prevention and Adherence Among HIV-infected Drug Users
NCT01741311
A Structural HIV Prevention Intervention Targeting High-risk Women
NCT04413591
Social Networks and Prevention for HIV Care and Prevention
NCT01800721
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Prevention & Testing Control
The comparison condition is focused on basic HIV risk reduction , safety and preventing drug overdose.
Prevention & Testing Control
7 group sessions
Prevention & Testing Intervention
The intervention condition is training on peer outreach skills which includes talking to HIV positive social network members about HIV care, medication adherence and HIV risk reduction.
Prevention & Testing
6 group sessions, 1 individual session, and 1 dyad session
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Prevention & Testing
6 group sessions, 1 individual session, and 1 dyad session
Prevention & Testing Control
7 group sessions
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. 18 years old or older
2. documentation of HIV positive status
3. report one of following risk behaviors in past 90 days: sharing injection equipment, use of crack cocaine, or unprotected vaginal or anal sex
Testing network
1. 18 or older
2. provided testing coupon provided by an index participant
Longitudinal network participant-
1. tested HIV negative at the Lighthouse via redeeming a testing coupon
2. reported interacting with index who gave the coupon at least weekly
3. report one of following risk behaviors in the prior 90 days: sharing injection equipment, use of crack cocaine, or unprotected vaginal or anal sex
Positive Networks
1. HIV positive
2. report one of following risk behaviors in the prior 90 days: sharing injection equipment, use of crack cocaine, or unprotected vaginal or anal sex
Exclusion Criteria
Testing network- already enrolled in the study as a Network participant
Longitudinal network- a) already enrolled in the study as a Network participant b) already enrolled in the study as a Index participant
Positive network- a) already enrolled in the study as a Network participant b) already enrolled in the study as a Index participant
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Drug Abuse (NIDA)
NIH
Johns Hopkins Bloomberg School of Public Health
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Carl Latkin
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Carl A Latkin, PhD
Role: PRINCIPAL_INVESTIGATOR
Johns Hopkins Bloomberg School of Public Health
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Lighhouse Studies @ Peer Point
Baltimore, Maryland, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.